Sep 12, 2015
"Per recommendations of EASL...http://www.easl.eu/medias/cpg/HEPC-2015/Full-report.pdf
Cirrhotic and/or treatment-experienced patients can be treated with an IFN-free combination of daily sofosbuvir (400 mg) and daily daclatasvir (60 m..."
Jul 03, 2015
""While the overall SVR rates with and without ribavirin were the same in these studies -- in which a majority of participants were treatment-naive and did not have cirrhosis -- ribavirin may still have a role to play in treating the most..."
Jul 03, 2015
"I certainly understand where RIBA continues to hold some value. But, my biggest excitement was that they are actually collecting data. This will prompt other studies. With such little data we are left to going with a docs personal instin..."
